Maddy summaryThe Combating Illicit Xylazine Act places xylazine - a veterinary sedative increasingly found in illicit drug mixtures - into Schedule III of the Controlled Substances Act, subjecting it to federal regulation as a controlled substance. It specifically allows veterinary use without requiring registration of the ultimate user (e.g., pet owners or veterinarians) if xylazine is dispensed by a registered veterinarian or pharmacy with a vet prescription and used for animals owned by the user, under their care, or in authorized animal programs. The bill provides a one-year delay for labeling and packaging requirements and a 60-day delay for registration and recordkeeping for veterinary use to ease implementation. Additionally, it adds xylazine to the Arcos tracking system for controlled substances and mandates two congressional reports on illicit use prevalence within 18 months and 4 years of enactment.
Sponsored bills
Maddy summaryThe National Quantum Initiative Reauthorization Act of 2026 reauthorizes and expands federal efforts to advance quantum information science, engineering, and technology through 2034. The bill establishes new workforce development programs, including quantum education initiatives, traineeships, and a Quantum Reskilling, Education, and Workforce Coordination Hub to address talent needs. It creates an International Quantum Cooperation Strategy to foster partnerships with allies and addresses quantum supply chain vulnerabilities through mapping and planning efforts. The act includes specific funding allocations for quantum research centers, testbeds, and post-quantum cryptography development, with annual evaluations required to assess program effectiveness. The legislation directly affects federal agencies, research institutions, and the quantum industry by providing structured funding and coordination for quantum technology advancement.
Maddy summaryThis bill extends federal funding for sport fish restoration and recreational boating safety through 2031, directly benefiting anglers, boaters, and conservation organizations. It updates the Dingell-Johnson Sport Fish Restoration Act by changing the funding period from 2026 to 2031 and modifies how multistate conservation grants are distributed. The key provision ensures each state receives the greater of 0.0375 percent of total appropriations or $200,000 for conservation projects, replacing the previous $1.2 million cap. These changes aim to provide more predictable and flexible funding for fisheries management and water safety initiatives across the United States.
Promoting Resilient Supply Chains Act of 2025 This bill requires the Industry and Analysis office of the International Trade Administration of the Department of Commerce to monitor and respond to disruptions in critical industries and supply chains. Specifically, the office must (1) establish the Supply Chain Resilience Working Group; (2) assess, map, and model critical supply chains; (3) identify high-priority supply chain gaps and vulnerabilities in critical industries; (4) identify and evaluate the effect of potential supply chain disruptions on market stability; and (5) collaborate with other governmental bodies and key international partners to identify opportunities to reduce supply chain gaps and vulnerabilities. Additionally, the office, in consultation with the working group and specified nongovernmental entities, must make recommendations and implement a strategy to improve the security and resiliency of manufacturing capacity and supply chains for critical industries (including critical industries for emerging technologies). The bill includes various reporting requirements.
Maddy summarySJRES 103 is a congressional disapproval resolution targeting a Department of Veterans Affairs (VA) rule on reproductive health services for veterans. The resolution, if passed, would block the VA rule from taking effect by invoking the Congressional Review Act (Chapter 8 of Title 5, U.S. Code), meaning the rule published in the Federal Register (December 31, 2025) would have no legal force. This directly affects the VA’s ability to implement new guidelines for reproductive health services at its facilities, preserving existing policies instead. The resolution does not create new policy but halts a specific administrative rule.
Maddy summaryS 921, titled "Tyler’s Law," requires the U.S. Department of Health and Human Services to study how often hospital emergency departments test for fentanyl during overdose cases, along with the costs, benefits, privacy impacts, and effects on patient-clinician relationships. The study must examine current testing frequency, associated costs, and how fentanyl testing might influence patient privacy and care. Within six months of completing the study, the Secretary must issue guidance on whether hospitals should routinely test for fentanyl, how to inform clinicians about testing protocols, and how such testing might affect future overdose risks and health outcomes. This bill directly affects hospitals with emergency departments and patients experiencing overdoses, but it does not mandate testing - it only mandates a study and subsequent guidance.
Maddy summaryThis bill, titled the Future of Artificial Intelligence Innovation Act of 2026, creates a new Center for Artificial Intelligence Standards and Innovation within the National Institute of Standards and Technology to develop voluntary testing standards, evaluation tools, and best practices for AI systems. The bill establishes testbed programs that allow companies of all sizes to access federal computing resources and facilities for testing AI technologies, while also creating international coalitions with like-minded countries to align on AI standards and security measures. It authorizes federal agencies to award prizes for solving specific AI challenges and requires a report identifying regulatory barriers that may hinder AI innovation. The legislation also expands hiring authority for technical experts and adds requirements for auditing temporary workers involved in AI research.
Maddy summaryS 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
Maddy summaryS 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
Maddy summaryThis bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.